Healthcare: Analyzing The Data

Looking at our custom HRM Indices, you can see the relative performance for the S&P 500 versus Medicare Exposure and Domestic Revenue. It appears that consensus moves lower for 2012 and 2013 were too aggressive and explain the bounce off the June lows as you can see in the chart.

 

A few other important themes worth noting here include:

  • Results are coming in weaker across companies particularly those with exposure to Europe.
  • Regarding our Physician Utilization theme, and a 2H12 recovery, the theme appears delayed but intact, the important point to keep in mind is that Q3 reports reflect softness we saw across our datasets through the summer.
  • Medicare outperformance remains, but has been the biggest relative loser over the last few weeks, coinciding with Romney’s election odds rising.
  • Healthcare has been a relative outperformer into broader market declines, but the current set up is neutral.
  • Beat-Miss:  2Q12 was the ugliest quarter in aggregate for reported topline growth vs. consensus since 1Q09 for both Healthcare and SPX constituent companies. The beat-miss ratio for 3Q12 is currently running ~40%/60% for the broader market.  Given the significant & expedited drawdown in estimates post 2Q12, missing or barely beating conservative & already deflated estimates is not a particularly bullish growth signal.

Healthcare: Analyzing The Data  - image003

 

Healthcare: Analyzing The Data  - image009

 

Healthcare: Analyzing The Data  - XLV


Who's Right? The Stock Market or the Bond Market?

"As I see it, bonds look like they have further to fall, while stocks look tenuous at these levels," writes Peter Atwater, founder of Financial Insyghts.

read more

Poll of the Day: If You Could Have Lunch with One Fed Chair...

What do you think? Cast your vote. Let us know.

read more

Are Millennials Actually Lazy, Narcissists? An Interview with Neil Howe (Part 2)

An interview with Neil Howe on why Boomers and Xers get it all wrong.

read more

6 Charts: The French Election, Nasdaq All-Time Highs & An Earnings Scorecard

We've been telling investors for some time that global growth is picking up, get long stocks.

read more

Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more

A 'Toxic Cocktail' Brewing for A Best Idea Short

The first quarter earnings pre-announcement today is not the end of the story for Mednax (MD). Rising labor costs and slowing volume is a toxic cocktail...

read more

Energy Stocks: Time to Buy? Here's What You Need to Know

If you're heavily-invested in Energy stocks it's been a heck of a year. Energy is the worst-performing sector in the S&P 500 year-to-date and value investors are now hunting for bargains in the oil patch. Before you buy, here's what you need to know.

read more